Matthew Feinsod insider trades

Open-market stock purchases and sales by Matthew Feinsod, Chief Medical Officer at Kalaris Therapeutics, Inc, from SEC Form 4 filings since Sep 14, 2017.

Recent trades

DateStockTradeValue
Mar 19, 2026KLRS Kalaris Therapeutics, IncBought (not open market)—

Companies traded

  • KLRS Kalaris Therapeutics, Inc: other filings, last Mar 19, 2026
  • AGTC Applied Genetic Technologies Corp: other filings, last Jul 29, 2019

Get free alerts when Matthew Feinsod files a new trade →